About
Aura Biosciences is a clinical-stage biotechnology company developing Virus-Like Drug Conjugates (VDCs) that selectively target and treat ocular cancers such as choroidal melanoma, for which there are currently no approved drug therapies.
Explore Aura Biosciences, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.